We sat down with Ria Westergaard, director of product innovation and a pharmacist who leads Evernorth's Clinical Trials team, to better understand the work her team does and how it improves patient outcomes. 

Dr. Stephanie Smith Cooney will establish Express Scripts’ Office of Independent Pharmacy Enablement and lead the industry’s first Independent Pharmacy Advisory Committee

Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar medications.

The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.

The Evernorth Research Institute analyzed aggregated and anonymized data of almost 5 million insured individuals to understand the prevalence of "cardiodiabesity" — a condition which encompasses cardiovascular disease, type 2 diabetes and obesity.

We sat down with Adam Kautzner, a pharmacist and the president of Express Scripts, who discussed some of our recent endeavors to improve access to quality care in rural America.

An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while preserving choice and flexibility for providers and patients.